About this trial
Dental care for people living with HIV has evolved with the widespread use of antiretroviral therapy, which has improved life expectancy and disease control. However, uncertainty remains about whether specific adaptations are still needed during dental procedures due to potential biological abnormalities that may increase infectious or bleeding risks.
This study aims to evaluate the proportion of patients living with HIV in the Pays de la Loire region who may require adapted dental management based on biological parameters such as immune status, hematological values, and comorbidities.
A retrospective descriptive study will be conducted using anonymized data from 5,603 patients followed in the COREVIH Pays de la Loire database. The results are expected to provide objective data to better inform dental practice and reduce unnecessary precautions or stigmatization in the management of patients living with HIV.
Eligibility criteria
Qualifiers
Adult patients aged ≥18 years
Confirmed diagnosis of HIV infection
Followed at participating hospital centers
Available clinical and biological data relevant to dental care management (CD4 count, viral load, blood count)
Disqualifiers
Patients with missing key biological data required for analysis
Patients not followed in participating centers
Patients with incomplete medical records preventing assessment of outcomes
Trial design
Treatments tested in this trial
- HIV infection status and clinical characteristics